|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 07, 2016 ) Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases.
For more information about this report: http://www.reportsweb.com/global-allergic-rhinitis-drugs-market-2016-2020 .
Publisher's analysts forecast the global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis.
The market is divided into the following segments based on geography:
- Americas
- APAC
- Europe
Publisher's report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001166598/buying .
Key vendors
- AstraZeneca
- GlaxoSmithKline
- Meda Pharmaceuticals
- Merck
- Sanofi
- UCB
Other prominent vendors
- Adamis Pharmaceuticals
- Alcon
- Alergo Pharma
- ALK-Abelló
- Allergy Therapeutics
- Almirall
- Ampio
- Anergis
- Apotex
- Ares Life Sciences
- Array BioPharma
- Aspen Pharmacare
- Atopix Therapeutics
- Barr Laboratories
- Belcher Pharmaceuticals
- Circassia Pharmaceuticals
- Dainippon Sumitomo
- DBV Technologies
- Dr Reddy's Laboratories
- Eddingpharm
- Genentech
- Greer Laboratories
- Hanmi Pharmaceuticals
- Hisamitsu Pharmaceutical
- Intas Pharmaceuticals
- Kyowa Hakko
- Lupin Pharmaceuticals
- Mitsubishi Tanabe Pharma
- Mylan
- Nektar Therapeutics
- Novartis
- Nuvo Research
- Nycomed
- Omega Pharma
Market driver
- Increased prevalence of allergic rhinitis
- For a full, detailed list, view our report
Market challenge
- Patent expiries and competition from generic drugs
- For a full, detailed list, view our report
Market trend
- Increased R&D
- For a full, detailed list, view our report
Buy Now at http://www.reportsweb.com/buy&RW0001166598/buy/2500 .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
